MYC and neoplasm: One landmark study demonstrated that systemic delivery of a miR-26a mimic via adeno-associated virus (AAV) reinstated miR-26a expression in a Myc-driven HCC mouse model, leading to widespread tumor cell cycle arrest and apoptosis without toxicity [103].